8102
-
Core Evidence
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Core Evidence
(309,003) Views
Editor in Chief Gulshan Sharma, MD
1555-175X
ReviewDasatinib: the emerging evidence of its potential in the treatment of chronic myeloid leukemia
Sonya Haslam
Core Evidence 2005, 1-Issues 1 & 2:0-0
31 March 2005
Review
Aliskiren in hypertension: evidence for its potential therapeutic value
Doris Peter
Core Evidence 2005, 1-Issues 1 & 2:0-0
31 March 2005
Review
Roflumilast: the evidence for its clinical potential in the treatment of chronic obstructive pulmonary disease
Linda Timm Wagner, Charlotte A. Kenreigh
Core Evidence 2005, 1-Issues 1 & 2:0-0
31 March 2005
Review
Pramipexole in restless legs syndrome: an evidence-based review of its effectiveness on clinical outcomes
William Winlow
Core Evidence 2005, 1-Issues 1 & 2:0-0
31 March 2005
Review
Sevelamer as a phosphate binder in adult hemodialysis patients: an evidence-based review of its therapeutic value
Carole Nadin
Core Evidence 2005, 1-Issues 1 & 2:0-0
31 March 2005
Review
Fosphenytoin for the treatment of status epilepticus: an evidence-based assessment of its clinical and economic outcomes
Andrew Thomson
Core Evidence 2005, 1-Issues 1 & 2:0-0
31 March 2005
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
